| ²é¿´: 607 | »Ø¸´: 4 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
yin198716гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÖú·Òë
|
||
| A further problem is that although this therapy is highly specific, patients are not selected on the basis of pathways of sensitivity or resistance in their tumors. |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ12È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ15È˻ظ´
Ò»Ö¾Ô¸0703»¯Ñ§ÕÐ61×îÖÕÅÅÃû62»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
277¡¢Ñ§Ë¶£¬Çóµ÷¼Á ÊýÒ»104£¬
ÒѾÓÐ10È˻ظ´
288»·¾³×¨Ë¶,Çóµ÷²ÄÁÏ·½Ïò
ÒѾÓÐ37È˻ظ´
328Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
338Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁϹ¤³Ì322
ÒѾÓÐ13È˻ظ´
304Çóµ÷¼Á£¨085602£¬¹ýËļ¶£¬Ò»Ö¾Ô¸985£©
ÒѾÓÐ25È˻ظ´

xilouyue008
гæ (³õÈëÎÄ̳)
- ·ÒëEPI: 1
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 16.9
- Ìû×Ó: 7
- ÔÚÏß: 1.8Сʱ
- ³æºÅ: 1036507
- ×¢²á: 2010-06-06
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
yin198716(phu_grassman´ú·¢): ½ð±Ò+3, ·ÒëEPI+1, thanks 2013-07-25 09:58:06
yin198716(phu_grassman´ú·¢): ½ð±Ò+3, ·ÒëEPI+1, thanks 2013-07-25 09:58:06
|
A further problem is that although this therapy is highly specific, patients are not selected on the basis of pathways of sensitivity or resistance in their tumors. ÁíÍâÒ»¸öÎÊÌâÊÇ£¬¾¡¹Ü¸ÃÁÆ·¨Ê®·Ö¾ßÓÐÕë¶ÔÐÔ£¬µ«ÊÇÕë¶ÔµÄ²¡È˲»ÊÇ»ùÓÚËûÃǵÄÖ×ÁöµÄÃô¸ÐÐÔ»òÄÍÒ©ÐÔ¶øåàÑ¡³öµÄ¡£ ½ö¹©²Î¿¼ ÂÛ̳Àï¿´µ½ºÃ¶àÈËÖ»·¢Ò»¾ä»°ÉÏÀ´ÇóÖú£¬Õâ¶ÔÓÚÇóÖúÕ߷dz£Óк¦¡£Ã»ÓÐÉÏÏÂÎÄ£¬Ìṩ°ïÖúµÄÈËÀí½â¿ÉÄÜÓÐÆ«²î¡£ |
2Â¥2013-05-04 10:55:32
yin198716
гæ (ÕýʽдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 1682.3
- É¢½ð: 1
- Ìû×Ó: 724
- ÔÚÏß: 566.6Сʱ
- ³æºÅ: 1574633
- ×¢²á: 2012-01-12
- רҵ: ºôÎüϵͳÖ×Áö

3Â¥2013-05-04 14:08:44
Ĉ?
Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)
Ժʿ
- ·ÒëEPI: 3
- Ó¦Öú: 362 (˶ʿ)
- ¹ó±ö: 0.021
- ½ð±Ò: 8586.3
- É¢½ð: 65
- ºì»¨: 45
- Ìû×Ó: 3288
- ÔÚÏß: 411.5Сʱ
- ³æºÅ: 2441785
- ×¢²á: 2013-04-29
- רҵ: Äý¾Û̬ÎïÐÔ II £ºµç×ӽṹ

4Â¥2013-05-04 17:56:17
hookhans
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
Farmer
- ·ÒëEPI: 263
- Ó¦Öú: 186 (¸ßÖÐÉú)
- ¹ó±ö: 0.142
- ½ð±Ò: 7949
- É¢½ð: 576
- ºì»¨: 51
- Ìû×Ó: 2089
- ÔÚÏß: 401.3Сʱ
- ³æºÅ: 2260260
- ×¢²á: 2013-01-25
- רҵ: ´ß»¯»¯Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
yin198716(phu_grassman´ú·¢): ½ð±Ò+1, thanks 2013-07-25 09:58:26
yin198716(phu_grassman´ú·¢): ½ð±Ò+1, thanks 2013-07-25 09:58:26
|
Òâ˼µ½Î»£¬µ«ºóÒ»¾äÎÒÒ²²»ÖªµÀʲôÒâ˼£¬·Çרҵ£¬²»Àí½â¡£¡¡ A further problem is that although this therapy is highly specific, patients are not selected on the basis of pathways of sensitivity or resistance in their tumors. ½øÒ»²½µÄÎÊÌâÊÇ£¬ËäÈ»ÕâÒ»ÁÆ·¨ÊǺÜÓÐÌØÐ§µÄ£¬µ«ÊDz¡È˲¢²»ÊÇ»ùÓÚÖ×ÁöÖеÄÃô¸Ð»ò¿¹²¡Ïß·¶øÑ¡Ôñ³öÀ´µÄ¡£ |

5Â¥2013-05-04 21:06:22














»Ø¸´´ËÂ¥